Association and interaction of the MC4R rs17782313 polymorphism with plasma ghrelin, GLP-1, cortisol, food intake and eating behaviors in overweight/obese Iranian adults.
Anxiety
Appetite
Depression
Emotional eating
Food intake
MC4R
Stress
Journal
BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676
Informations de publication
Date de publication:
19 Sep 2022
19 Sep 2022
Historique:
received:
18
11
2021
accepted:
16
08
2022
entrez:
19
9
2022
pubmed:
20
9
2022
medline:
23
9
2022
Statut:
epublish
Résumé
Recent studies have shown that obesity is largely influenced by heredity and created by the interactions between several genes and environmental and behavioral factors. This study aimed to examine association between variant rs17782313 near melanocortin-4 receptor (MC4R) gene and behavioral and hormonal factors then evaluated interactions between variant MC4R rs17782313 with behavioral and hormonal factors on obesity. This cross-sectional study included 403 subjects, overweight and/or obesity, aged 20-50 years from Iran. The MC4R rs17782313 data were measured by the PCR-RFLP method. Dietary intake, physical activity, stress, anxiety, depression, appetite and emotional eating were assessed by using validated questionnaires. Ghrelin, glucagon-like peptide-1 and cortisol were measured by radioimmunoassay in plasma samples. Participants were also divided into three groups based on rs17782313 genotype and BMI. After adjustment for age, gender, energy intake and PA, significant associations were observed between food intake, appetite, emotional eating, stress and physical activity with MC4R rs17782313 (p ˂0.05). Also, significant interactions were observed between fat intake (p-interaction = 0.002), protein intake (p-interaction = 0.01), energy intake (p-interaction = 0.01), emotional eating (p-interaction = 0.02), appetite (p-interaction = 0.04), stress (p-interaction = 0.04), ghrelin (p-interaction = 0.03), cortisol (p-interaction = 0.04) and physical activity (p-interaction = 0.04) and MC4R rs17782313 in terms of BMI. Interactions between the CC genotype and high intakes of fat and energy, emotional eating, high appetite, and too much stress with high levels of cortisol and ghrelin probably can have an effect on BMI in overweight/obese subjects.
Sections du résumé
BACKGROUND
BACKGROUND
Recent studies have shown that obesity is largely influenced by heredity and created by the interactions between several genes and environmental and behavioral factors. This study aimed to examine association between variant rs17782313 near melanocortin-4 receptor (MC4R) gene and behavioral and hormonal factors then evaluated interactions between variant MC4R rs17782313 with behavioral and hormonal factors on obesity.
METHODS
METHODS
This cross-sectional study included 403 subjects, overweight and/or obesity, aged 20-50 years from Iran. The MC4R rs17782313 data were measured by the PCR-RFLP method. Dietary intake, physical activity, stress, anxiety, depression, appetite and emotional eating were assessed by using validated questionnaires. Ghrelin, glucagon-like peptide-1 and cortisol were measured by radioimmunoassay in plasma samples. Participants were also divided into three groups based on rs17782313 genotype and BMI.
RESULTS
RESULTS
After adjustment for age, gender, energy intake and PA, significant associations were observed between food intake, appetite, emotional eating, stress and physical activity with MC4R rs17782313 (p ˂0.05). Also, significant interactions were observed between fat intake (p-interaction = 0.002), protein intake (p-interaction = 0.01), energy intake (p-interaction = 0.01), emotional eating (p-interaction = 0.02), appetite (p-interaction = 0.04), stress (p-interaction = 0.04), ghrelin (p-interaction = 0.03), cortisol (p-interaction = 0.04) and physical activity (p-interaction = 0.04) and MC4R rs17782313 in terms of BMI.
CONCLUSION
CONCLUSIONS
Interactions between the CC genotype and high intakes of fat and energy, emotional eating, high appetite, and too much stress with high levels of cortisol and ghrelin probably can have an effect on BMI in overweight/obese subjects.
Identifiants
pubmed: 36123585
doi: 10.1186/s12902-022-01129-w
pii: 10.1186/s12902-022-01129-w
pmc: PMC9487018
doi:
Substances chimiques
Ghrelin
0
MC4R protein, human
0
Receptor, Melanocortin, Type 4
0
Transcription Factors
0
Glucagon-Like Peptide 1
89750-14-1
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
234Subventions
Organisme : Tehran University of Medical Sciences (TUMS)
ID : 40783
Informations de copyright
© 2022. The Author(s).
Références
Biol Psychiatry. 2004 Nov 1;56(9):665-9
pubmed: 15522250
Front Endocrinol (Lausanne). 2020 Jul 07;11:437
pubmed: 32733386
Curr Obes Rep. 2019 Jun;8(2):77-87
pubmed: 31037612
J Clin Endocrinol Metab. 2010 Apr;95(4):1998-2002
pubmed: 20147580
Int J Obes (Lond). 2015 Jan;39(1):114-20
pubmed: 24827639
Cell Metab. 2014 Dec 2;20(6):1018-29
pubmed: 25453189
Eur J Epidemiol. 2011 Jun;26(6):463-73
pubmed: 21544599
J Nutr. 2010 Apr;140(4):831-4
pubmed: 20181787
PLoS Genet. 2017 Apr 27;13(4):e1006528
pubmed: 28448500
Biol Res Nurs. 2015 May;17(3):295-302
pubmed: 25230746
Pharmacol Res. 2021 Oct;172:105847
pubmed: 34438062
Cell Metab. 2018 Jul 03;28(1):23-32.e3
pubmed: 29861388
Pers Soc Psychol Bull. 2010 Jun;36(6):792-804
pubmed: 20460650
Appetite. 2018 Sep 1;128:197-204
pubmed: 29920323
Mol Nutr Food Res. 2011 Jan;55(1):136-49
pubmed: 21207518
Behav Brain Res. 2013 Aug 1;250:139-47
pubmed: 23680165
PLoS One. 2012;7(12):e52344
pubmed: 23284998
J Pers Med. 2021 Oct 12;11(10):
pubmed: 34683161
PLoS One. 2014 Jun 06;9(6):e99152
pubmed: 24905098
Am J Clin Nutr. 2009 Oct;90(4):951-9
pubmed: 19692490
Cell. 2005 Nov 4;123(3):493-505
pubmed: 16269339
Int J Neuropsychopharmacol. 2013 Feb;16(1):105-20
pubmed: 22176700
Endocrinology. 2020 Aug 1;161(8):
pubmed: 32516384
Physiol Behav. 2011 Mar 28;102(5):491-5
pubmed: 21172367
Diabetes. 2006 Feb;55(2):559-62
pubmed: 16443795
Peptides. 2020 Sep;131:170342
pubmed: 32522585
PLoS One. 2015 Mar 26;10(3):e0121768
pubmed: 25811380
Prog Mol Biol Transl Sci. 2013;114:147-91
pubmed: 23317785
J Clin Endocrinol Metab. 2012 Jun;97(6):E1023-31
pubmed: 22492873
Hum Mol Genet. 2008 Nov 15;17(22):3502-8
pubmed: 18697794
Eat Weight Disord. 2021 May;26(4):1079-1087
pubmed: 32918257
Nutr Hosp. 2012 Mar-Apr;27(2):645-51
pubmed: 22732995
Clin Biochem. 2013 Mar;46(4-5):313-6
pubmed: 23201545
Gene. 2015 Jun 1;563(2):125-9
pubmed: 25769385
Nutr Metab (Lond). 2016 May 21;13:38
pubmed: 27213003
Int J Obes (Lond). 2013 Aug;37(8):1027-35
pubmed: 23147118
Stress. 2019 Sep;22(5):571-580
pubmed: 31184537
Nature. 2015 Apr 2;520(7545):94-8
pubmed: 25600267
Biol Psychiatry. 2013 May 1;73(9):827-35
pubmed: 23541000
Nat Neurosci. 2014 Jul;17(7):911-3
pubmed: 24908101
J Am Diet Assoc. 1994 Jun;94(6):626-30
pubmed: 8195550
Hum Genet. 2014 Nov;133(11):1431-41
pubmed: 25103139
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):328-35
pubmed: 22579533
Int J Obes (Lond). 2009 Mar;33(3):373-8
pubmed: 19153581
Br J Nutr. 2018 Aug;120(4):454-463
pubmed: 29893663
J Physiol Biochem. 2014 Mar;70(1):255-62
pubmed: 24307561
Am J Clin Nutr. 2010 Feb;91(2):321-8
pubmed: 20007308
J Biol Chem. 2018 Jul 13;293(28):10993-11005
pubmed: 29794140
BMC Endocr Disord. 2022 May 10;22(1):121
pubmed: 35538513
Asian J Sports Med. 2011 Jun;2(2):106-16
pubmed: 22375226
Obesity (Silver Spring). 2017 Apr;25(4):713-720
pubmed: 28349668
Mol Genet Metab. 2011 May;103(1):71-5
pubmed: 21303735
Int J Obes (Lond). 2018 Sep;42(9):1602-1609
pubmed: 29568105
Am J Epidemiol. 2012 Feb 15;175(4):340-7
pubmed: 22273536
Obes Res. 2000 Nov;8(8):597-603
pubmed: 11156436
PLoS One. 2011 Apr 22;6(4):e19107
pubmed: 21544212
PLoS One. 2013 Sep 16;8(9):e74362
pubmed: 24066140
Am J Epidemiol. 2011 Jun 1;173(11):1256-62
pubmed: 21527513
Stress. 2015;18(4):381-99
pubmed: 26303312
Trends Neurosci. 2017 Mar;40(3):167-180
pubmed: 28108113
Clin Epidemiol. 2017 Mar 28;9:185-193
pubmed: 28405173
Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39
pubmed: 16004657
J Clin Endocrinol Metab. 2005 Jan;90(1):6-9
pubmed: 15483072